Activity of the Estrogen-Metabolizing Enzyme Cytochrome P450 1B1 Influences the Development of Pulmonary Arterial Hypertension
Author(s) -
Kevin P. White,
Anne Katrine Johansen,
Margaret Nilsen,
Loredana Ciuclan,
Emma Wallace,
Leigh Paton,
A. Campbell,
Ian Morecroft,
Lynn Loughlin,
John McClure,
Matthew J. Thomas,
Kirsty M. Mair,
Margaret R. MacLean
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.062927
Subject(s) - cyp1b1 , pulmonary artery , right ventricular hypertrophy , estrogen , endocrinology , medicine , metabolite , pulmonary hypertension , cytochrome p450 , estrogen receptor , hypoxia (environmental) , pharmacology , chemistry , metabolism , cancer , breast cancer , organic chemistry , oxygen
Pulmonary arterial hypertension (PAH) is a hyperproliferative vascular disorder observed predominantly in women. Estrogen is a potent mitogen in human pulmonary artery smooth muscle cells and contributes to PAH in vivo; however, the mechanisms attributed to this causation remain obscure. Curiously, heightened expression of the estrogen-metabolizing enzyme cytochrome P450 1B1 (CYP1B1) is reported in idiopathic PAH and murine models of PAH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom